ranitidine and HIV Coinfection
ranitidine has been researched along with HIV Coinfection in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Alexander, WJ; Bartlett, JA; Berry, PS; Bockman, KW; DeMasi, R; Graham, S; Johnson, J; Quinn, J; Stein, A | 1 |
Barditch-Crovo, PA; Gambertoglio, J; Hafner, R; Kornhauser, DM; Kuwahara, S; Lietman, PS; Nerhood, LJ; Petty, BG | 1 |
Dickmeiss, E; Georgsen, J; Kehlet, H; Mathiesen, L; Moesgaard, F; Nielsen, JO; Nielsøn, HJ; Pedersen, C; Svenningsen, A | 1 |
Trials
3 trial(s) available for ranitidine and HIV Coinfection
Article | Year |
---|---|
A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection.
Topics: Adult; beta 2-Microglobulin; CD4 Lymphocyte Count; CD56 Antigen; CD8 Antigens; Double-Blind Method; Female; Histamine H2 Antagonists; HIV; HIV Core Protein p24; HIV Infections; Humans; Male; Plasma; Ranitidine; RNA, Viral | 1998 |
The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet.
Topics: Administration, Oral; Antiviral Agents; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Foscarnet; Gastric Acid; Histamine H2 Antagonists; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Ranitidine | 1998 |
Ranitidine improves certain cellular immune responses in asymptomatic HIV-infected individuals.
Topics: Adult; Double-Blind Method; HIV Antibodies; HIV Infections; Humans; Interferon Type I; Interleukin-2; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Ranitidine; Receptors, Interleukin-2; Recombinant Proteins; T-Lymphocyte Subsets | 1991 |